Skip to main content
Pharming Group N.V. (AMS:PHARM)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
0.8715
-0.0010 (-0.11%)
May 13, 2025, 5:35 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Recombinant Human C1 Esterase Inhibitor
226.91M
Log In
Log In
Log In
Log In
Recombinant Human C1 Esterase Inhibitor Growth
15.98%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
221.17M
Log In
Log In
Log In
Log In
United States Growth
16.17%
Log In
Log In
Log In
Log In
Europe and Rest of World
5.74M
Log In
Log In
Log In
Log In
Europe
-
Log In
Log In
Log In
Log In
Europe Growth
-
Log In
Log In
Log In
Log In
Rest of the World
-
Log In
Log In
Log In
Log In
Rest of the World Growth
-
Log In
Log In
Log In
Log In